Effects of three abnormal conditions of fallopian tube on outcomes of the in vitro fertilization and embryo transfer technique

Chengjun Liu,Ketong Su,Meng Tian,Huili Ji,Lina Sun,Chunjin Li,Xu Zhou
DOI: https://doi.org/10.1111/jog.14306
2020-06-04
Journal of Obstetrics and Gynaecology Research
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>The aim of this study was to demonstrate whether salpingitis affects the outcomes of in vitro fertilization and embryo transfer (IVF‐ET).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The retrospective study includes patients from 2013 to 2018 who received their first IVF‐ET treatment during this period. On the basis of their tubal conditions, the patients were subgrouped as: hydrosalpinx (group A), salpingitis (group B), tubal occlusion (group C). It had a total of 726 cycles, of which 208 cycles were in group A, 201 cycles in group B and 317 cycles in group C. The outcomes of the IVF‐ET treatment were compared amongst the three groups.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Group C had the highest number of retrieved oocytes as compared to the groups A and B, and the rate of the high‐quality embryos at day 3 (66–68 h after insemination) was higher in the groups C and A compared to the group B. The blastocyst formation rate was significantly higher in group C compared to that of the group B. Group C had higher rates of implantation, clinical pregnancy and live birth compared to both groups A and B, while the birth weight of newborns did not differ amongst the three groups.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Salpingitis has adverse effects on the success rate of the IVF‐ET treatment, exemplified by lower implantation, clinical pregnancy and live birth rates compared to tubal occlusion, it may be necessary to carry out appropriate management of salpingitis before IVF‐ET treatment.</p></section>
obstetrics & gynecology
What problem does this paper attempt to address?